Your account is not claimed yet. You can sign up with ORCID to claim your account.

Haineng Xu

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Signaling Pathway

Dna Damage Response

Top Venues

Research square

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

University of Pennsylvania

Institute of Biochemistry and Cell Biology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pennsylvania Jun 1o 2017

United States

Postdoctoral Researcher :: Ovarian Cancer Research Center

Education History

Institute of Biochemistry and Cell Biology Sep 1o 2008 - Jul 1o 2013

China

PHD :: Institute of Biochemistry and Cell Biology

Publications

Sarah B Gitto, Margaret E Whicker, Gareth Davies, Sushil Kumar, Krista Kinneer, Haineng Xu, Arthur Lewis, Srinivas Mamidi, Sergey Medvedv, Hyoung Kim, Judith Anderton, E Jessica Tang, Benjamin Ferman, Steven Coats, Robert W Wilkinson, Eric J Brown, Daniel J Powell, Fiona Simpkins
A B7-H4 targeting antibody-drug conjugate shows anti-tumor activity in PARPi and platinum resistant cancers with B7-H4 expression. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fiona Simpkins, Yasuto Kinose, Haineng Xu, Hyoung Kim, Sushil Kumar, Xiaoyin Shan, Erin Geroge, Xiaolei Wang, Sergey Medvedev, Benjamin Ferman, Sarah Gitto, Margaret Whicker, Kurt D Andrea, Bradley Wubbenhorst, Dorothy Hallberg, Lenka Oplustil O'Connor, Lauren Schwartz, Wei-Ting Hwang, Katherine L Nathanson, Gordon B Mills, Victor E Velculescu, Tian-Li Wang, Eric Brown, Ronny Drapkin
Dual blockade of BRD4 and ATR/WEE1 pathways exploits ARID1A loss in clear cell ovarian cancer. Research square (2023)
Hyoung Kim, Haineng Xu, Erin George, Dorothy Hallberg, Sushil Kumar, Veena Jagannathan, Sergey Medvedev, Yasuto Kinose, Kyle Devins, Priyanka Verma, Kevin Ly, Yifan Wang, Roger A Greenberg, Lauren Schwartz, Neil Johnson, Robert B Scharpf, Gordon B Mills, Rugang Zhang, Victor E Velculescu, Eric J Brown, Fiona Simpkins
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models. Nature communications 11 (1) (2020)